title: Pathobiology of transfusion reactions.
abstract: Antibody-induced hemolytic transfusion reactions were first described over 300 years ago. Indeed, during its early evolution, transfusion medicine focused almost exclusively on issues in immunohematology to prevent such events. However, despite the best of efforts to avoid them, incompatible transfusions still occur, through both error and an inability to obtain compatible red blood cells for patients who are alloimmunized against multiple antigens. Because transfusing units of incompatible blood is potentially lethal, studies on human volunteers are not ethical. Thus, understanding of hemolytic transfusion reactions is generated through clinical cases, animal models, inference from related human pathologies, or studies using small volumes of transfused red blood cells. Over the past several decades, substantial new knowledge has been accumulated regarding the mechanisms of hemolysis, the metabolism of products of hemolysis, and the effects of both on recipient biology. Using these data sources, this article traces the historical generation of this knowledge and describes recent advances.
authors.affiliation: Puget Sound Blood Center Research Institute, Seattle, Washington 98102; email: jzimring@psbc.org.
authors.forename: James C
authors.initials: JC
authors.lastname: Zimring
authors.forename: Steven L
authors.initials: SL
authors.lastname: Spitalnik
mesh_terms: D000818:Animals; D001787:Blood Group Incompatibility / Q000097:blood* / Q000276:immunology / Q000473:pathology; D006801:Humans; D065227:Transfusion Reaction / Q000276:immunology / Q000473:pathology*
keywords: hemolysis; red blood cells; transfusion reactions